Benefits
Modest fat absorption reduction
Chitosan's positive charge binds negatively charged dietary fatty acids in the acidic stomach, forming a viscous gel that passes into the small intestine partially resisting lipase digestion. Clinical studies confirm chitosan reduces fat absorption by approximately 1–2% of total dietary fat — a modest effect that translates to only modest caloric reduction. The fat-blocking effect is real but much smaller than marketing claims suggest.
Cholesterol reduction
By binding bile acids and dietary cholesterol in the GI tract, chitosan reduces cholesterol absorption and enterohepatic bile acid recirculation — producing modest but consistent reductions in total cholesterol and LDL cholesterol. A meta-analysis confirms significant LDL reductions of approximately 10 mg/dL with chitosan supplementation.
Blood pressure support
Several clinical studies show chitosan supplementation modestly reduces blood pressure in hypertensive subjects — possibly through fat and cholesterol binding effects, reduced sodium absorption, or direct ACE-inhibitory activity of chitosan oligomers. Effects are modest and inconsistent across trials.
Wound healing (topical)
Chitosan has the strongest evidence in wound healing applications — as a topical hemostatic and wound dressing material. Its positive charge promotes platelet aggregation, its antimicrobial properties reduce wound infection risk, and its structure provides a scaffold for tissue regeneration. FDA-cleared chitosan-based wound dressings are used clinically.
Mechanism of action
Electrostatic fat binding via positive charge
Chitosan's free amino groups are protonated in the acidic stomach environment, creating a strongly cationic polymer. Dietary fatty acids (negatively charged carboxylate groups) electrostatically bind to chitosan, forming a viscous complex that partially resists pancreatic lipase digestion in the small intestine and reduces fatty acid absorption.
Bile acid sequestration and cholesterol reduction
Like other dietary fibers, chitosan binds bile acids in the intestinal lumen, preventing their reabsorption. Hepatic cholesterol is then converted to new bile acids, reducing serum cholesterol and increasing LDL receptor expression. The cationic nature of chitosan provides relatively efficient bile acid binding compared to neutral fibers.
Prebiotic and microbiome modulation
Chitosan that escapes fat binding is fermented by colonic bacteria, producing short-chain fatty acids and selectively feeding Bifidobacterium populations. This prebiotic effect contributes to metabolic health benefits beyond direct fat absorption reduction.
Clinical trials
Evidence review and pooled analysis of 15 randomized controlled trials examining chitosan supplementation for weight loss and metabolic parameters. (Cochrane Database Syst Rev)
Pooled across 15 clinical trials.
Chitosan produced statistically significant but clinically modest reductions in body weight (-1.7 kg average), LDL cholesterol, and blood pressure vs placebo. Authors noted that high-quality trials showed smaller effects than low-quality trials, suggesting inflated estimates in earlier literature. Cochrane conclusion: minimal clinical relevance of chitosan for weight loss alone.